New AI algorithm accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome at scale for the first time Illumina unveiled
Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease Illumina Inc. and Tempus AI, Inc. a technology company leading
Illumina, Inc., a global leader in next-generation sequencing and array-based technologies, announced a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects
Illumina, a global leader in genomic sequencing and analysis, announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of
Fuel up with free Health Tech Insights
